Abstract:Alzheimer's disease (AD), one of the most common types of chronic neurodegenerative diseases, is pathologically characterized by the formation of amyloid beta (A beta) peptide-containing plaques and neurofibrillary tangles. Among A beta peptides, A beta(1-42) induces neuronal toxicity and neurodegeneration. In our previous studies, Cdk5 was found to regulate A beta(1-42)-induced mitochondrial fission via the phosphorylation of dynamin-related protein 1 (Drp1) at Ser579. However, whether blockage of Drp1 phosphorylation at Ser579 protects neurons against A beta(1-42)-induced degeneration remains to be elucidated. Thus, the aim the present study was to examine the effect of mutant Drp1-S579A on neurodegeneration and its underlying mechanism. First, the phosphorylation-defect (phospho-defect) mutant, Lenti-Drp1-S579A was constructed. Phospho-defect Drp1-S579A expression was detected in primary cultures of mouse cortical neurons infected with Lenti-Drp1-S579A using western blotting and it was found to successfully attenuate the phosphorylation of endogenous Drp1 at Ser579. In primary neuronal cultures, the neuronal processes were evaluated under microscopy. Treatment with 10 mu M A beta(1-42) significantly decreased dendritic density and length, spine outgrowth and synapse number. As expected, infection of neurons with Lenti-Drp1-S579A efficiently alleviated the inhibitory effect of A beta(1-42) on neurite outgrowth and synapse density. In addition, infection with Lenti-Drp1-S579A abolished the cleavage of caspase-3 and apoptosis in neurons exposed to A beta(1-42). Thus, the current data demonstrated that blockage of Drp1 phosphorylation at Ser579 may be an effective strategy to protect neurons against A beta(1-42)-induced degeneration and apoptosis. These findings underline the therapeutic potential of targeting Drp1 in the treatment of AD.

Downregulation Of Rbo-Pi4kiii Alpha Facilitates A Beta(42) Secretion And Ameliorates Neural Deficits In A Beta(42)-Expressing Drosophila

Downregulation of RBO-PI4KIIIα Facilitates Aβ Secretion and Ameliorates Neural Deficits in Aβ-Expressing .

TTC7 and Hyccin Regulate Neuronal Aβ42 Accumulation and Its Associated Neural Deficits in Aβ42-Expressing Drosophila

PI3 Kinase Signaling is Involved in Aβ-induced Memory Loss in Drosophila

A Functional Mouse Retroposed Gene Rps23r1 Reduces Alzheimer's Β-Amyloid Levels and Tau Phosphorylation

Rps23rg1 Reduces A Beta Oligomer-Induced Synaptic And Cognitive Deficits

Blockage Of Drp1 Phosphorylation At Ser579 Protects Neurons Against A Beta(1-42)-Induced Degeneration

Dicer1 promotes Aβ clearance via blocking B2 RNA-mediated repression of apolipoprotein E

Down-Regulation of KV4 Channel in Drosophila Mushroom Body Neurons Contributes to Aβ42-Induced Courtship Memory Deficits

Rpph1 Upregulates CDC42 Expression and Promotes Hippocampal Neuron Dendritic Spine Formation by Competing with Mir-330-5p.

RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits

A Novel Rhamnoside Derivative PL402 Up-Regulates Matrix Metalloproteinase 3/9 to Promote Aβ Degradation and Alleviates Alzheimer’s-like Pathology

Dissecting The Pathological Effects Of Human A Beta 40 And A Beta 42 In Drosophila: A Potential Model For Alzheimer'S Disease

Amyloid-β Depresses Excitatory Cholinergic Synaptic Transmission in Drosophila

The Rps23r1 gene family regulates Alzheimer's beta-amyloid generation and tau phosphorylation

Down-regulation Amyloid Beta-Protein 42 Production by Interfering with Transcript of Presenilin 1 Gene with Sirna.

Genetic Inhibition of PDK1 Robustly Reduces Plaque Deposition and Ameliorates Gliosis in the 5×FAD Mouse Model of Alzheimer's Disease

Linking aβ42-induced hyperexcitability to neurodegeneration, learning and motor deficits, and a shorter lifespan in an Alzheimer's model.

P2‐312: the Rps23r1 Gene Family Regulates Alzheimer's Beta‐amyloid Generation and Tau Phosphorylation

NDRG4 Alleviates Aβ1–40 Induction of SH-SY5Y Cell Injury Via Activation of BDNF-Inducing Signalling Pathways

Ribosylation-Derived Advanced Glycation End Products Induce Tau Hyperphosphorylation Through Brain-Derived Neurotrophic Factor Reduction.